Compass Pathways announced that its investigational psilocybin treatment has successfully met its primary endpoint in a Phase 3 trial in depression.
Odamtten Sets New School Record in 60m Dash at Harvard Classic Men's Track and Field 12.06.2025 Huskies Kick Off 2025-26 Indoor Season with Two Meets Men's Track and Field 12.04.2025 Track & Field ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results